Halozyme Therapeutics Market Cap

Halozyme Therapeutics has a market cap or net worth of 159.56 billion as of September 2, 2025. Its market cap has increased by 14.28% in one year.

Market Cap

159.56B

Enterprise Value

178.02B

Revenue

22.23B

Ranking

n/a

PE Ratio

15.18

Stock Price

1,121.86

Market Cap Chart

Since May 14, 2004, Halozyme Therapeutics's market cap has increased from 1.94B to 159.56B, an increase of 8,111.78%. That is a compound annual growth rate of 22.97%.

Market Cap History

Date	Market Cap	% Change
Sep 2, 2025	160.67B	26.76%
Dec 31, 2024	126.75B	53.56%
Dec 29, 2023	82.54B	-45.00%
Dec 30, 2022	150.07B	29.37%
Dec 31, 2021	116.00B	1.13%
Dec 31, 2020	114.71B	134.71%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Wal-Mart de México	965.41B
Grupo Financiero Banorte	475.80B
Arca Continental	322.60B
Industrias Peñoles	241.86B
GMéxico Transportes	142.37B
FIBRA Prologis	110.52B
Fibra UNO	99.85B
Promotora y Operadora de Infraestructura, S. A. B. de C. V.	97.81B

Market Cap Rankings